Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Henze

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Leukemia|September 20, 2000
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivoA Prokop, T Wieder, I Sturm, et al.
Klinische Padiatrie|May 1, 1984
[BFM study 1981/83 of the treatment of highly malignant non-Hodgkin's lymphoma in children: results of therapy stratified according to histologic immunological type and clinical stage]S Müller-Weihrich, J Beck, G Henze, et al.
Blood|January 11, 2000
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group reportA Reiter, M Schrappe, W D Ludwig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86E Koscielniak, D Harms, G Henze, et al.
Leukemia|October 30, 2001
Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblastsT Wieder, A Prokop, B Bagci, et al.
Bone Marrow Transplantation|August 1, 1990
Soluble interleukin 2 receptors in patients after bone marrow transplantationW Siegert, O Josimovic-Alasevic, R Schwerdtfeger, et al.
Cytokine|October 29, 2000
Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood allA Korte, J Köchling, L Badiali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster GroupA Reiter, M Schrappe, R Parwaresch, et al.
Blood|March 21, 1998
TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study GroupK Seeger, H P Adams, D Buchwald, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Contouring structures for 3-dimensional treatment planningR J Dowsett, J M Galvin, E Cheng, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Leukemia|September 20, 2000
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivoA Prokop, T Wieder, I Sturm, et al.
Klinische Padiatrie|May 1, 1984
[BFM study 1981/83 of the treatment of highly malignant non-Hodgkin's lymphoma in children: results of therapy stratified according to histologic immunological type and clinical stage]S Müller-Weihrich, J Beck, G Henze, et al.
Blood|January 11, 2000
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group reportA Reiter, M Schrappe, W D Ludwig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86E Koscielniak, D Harms, G Henze, et al.
Leukemia|October 30, 2001
Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblastsT Wieder, A Prokop, B Bagci, et al.
Bone Marrow Transplantation|August 1, 1990
Soluble interleukin 2 receptors in patients after bone marrow transplantationW Siegert, O Josimovic-Alasevic, R Schwerdtfeger, et al.
Cytokine|October 29, 2000
Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood allA Korte, J Köchling, L Badiali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster GroupA Reiter, M Schrappe, R Parwaresch, et al.
Blood|March 21, 1998
TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study GroupK Seeger, H P Adams, D Buchwald, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Contouring structures for 3-dimensional treatment planningR J Dowsett, J M Galvin, E Cheng, et al.
Pageof 24